Pharma stocks are doing very well: Emkay Global Financial Services

Now pharma is a main buzz word. So anything which has pharma behind its name or any of its activity that is pharma besides its name the stocks are doing very well.

In a chat with ET Now, Anish Damania, Head-Institutional Equity, Emkay Global Financial Services Ltd, shares his views on pharma sector.

ET Now: What is your call on midcap pharma?

Anish Damania: There are four sectors which one can invest in and those sectors are pharma, IT, autos and FMCG. Now pharma is a main buzz word. So anything which has pharma behind its name or any of its activity that is pharma besides its name the stocks are doing very well. So you saw Panacea Biotec move up firmly over the last few days. Jubilant Lifesciences moved up quite significantly over the past few days. So you are seeing that action catching up in some stocks, which have not done anything over the last few months in the pharma space. Similar is a case with technology, so if you look at the midcap technology space a lot of stocks have started buzzing once again.
ADVERTISEMENT
READ MORE

READ MORE:

LOGIN & CLAIM

50 TIMESPOINTS

More from our Partners

Loading next story
Business News › Markets › Stocks › Recos › Pharma stocks are doing very well: Emkay Global Financial Services
Text Size:AAA
Success
This article has been saved

*

+